Predict your next investment

Addis Pharmaceutical Factory company logo
HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer


Private Equity | Alive

Total Raised


Last Raised

$42M | 6 yrs ago

About Addis Pharmaceutical Factory

Addis Pharmaceutical (APF) manufactures a significant number of pharmaceutical products across different therapeutic categories that it supplies primarily to the Ethiopian market. The company manufactures more than 91 high quality pharmaceutical products of different therapeutic categories including Antibiotics, Gastro-intestinal drugs, Central Nervous system drugs, Cardiovascular drugs, anti diabetic agents, Antihistamines and Anti allergic, Antihelminthics, analgesics, Antiprotozoals,Respiratory drugs, dermatologicalsand Minerals and Vitamins and Large volume Parenterals; in various dosage forms.

Addis Pharmaceutical Factory Headquarter Location

79 Adigrat




Latest Addis Pharmaceutical Factory News

54 Capital invests $42m in Ethiopia’s Addis Pharmaceutical Factory

Jan 8, 2016

ACCEPT COOKIES We use cookies to create the best possible browsing experience for AltAssets website visitors. By closing this box you agree to the use of cookies according to our privacy & cookies policy . 54 Capital invests $42m in Ethiopia’s Addis Pharmaceutical Factory 8 Jan 2016 54 Capital, a private equity firm focused on investments in Africa, has backed Ethiopia’s drug manufacturer Addis  Pharmaceutical  Factory with $42m. The firm has made and initial investment of $30m with an option to provide further $12m in financing which Addis plans to use for improving production capacity and enhancing its product portfolio. With the local government putting a priority in its future development, Ethiopia’s pharmaceutical sector is expected to growth to $1bn by 2018 at the latest. Saad Aouad, founder and CIO of 54 Capital, said, ” The Ethiopia pharmaceutical sector is one of the most exciting industries in the country and is poised to witness a high level of demand in the coming years. “Through our investment into APF we will be both partnering with EFFORT, an investment group dedicated to transforming the Ethiopian business landscape, and investing into one of the leading companies in the country; marking our recognition of the importance of the sector in Ethiopia and our continued commitment to the country.” Founded in 2013 54 Capital is an Africa-focused asset management firm. In 2013, 54 Capital invested €5m into the largest private university in Morocco, UPM. Apart from the current deal it has so far invested around $35m into the FMCG sector in Ethiopia since 2014. In 2011, Aouad originated and took part in one of the largest private equity deals to date in Ethiopia – a $90m growth capital investment in the second-largest and only remaining independent brewery in the country. Copyright © 2016 AltAssets No related posts. AltAssets Mobile App To access the latest private equity news and stories download the new AltAssets mobile app from the

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Addis Pharmaceutical Factory

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Addis Pharmaceutical Factory is included in 5 Expert Collections, including Pharma Startups.


Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.



2,144 items

Companies developing products that monitor, analyze, protect, or otherwise influence the structure/function of the nervous system.



5,880 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Infectious Disease

2,226 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.



1,750 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.